CCP110

Across TCGA pan-cancer cohorts, CCP110 RNA differs between tumor and matched normal tissue in 12 of 18 cancer types tested, making tumor–normal expression one of CCP110’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where CCP110 RNA is repressed in tumor relative to normal tissue. In most cancer types CCP110 is over-expressed in tumor, although a few such as THCA and KICH show the opposite, repressed pattern.

THCA, KICH, and KIRP are the cancer types where CCP110 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CCP110 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	Male	All	−0.882	<.001	8	view →
KICH	Female	All	−1.115	<.001	7	view →
KIRP	All	IV	+0.724	.013	6	view →
HNSC	Male	All	+0.491	.002	6	view →
CHOL	Male	All	+1.773	<.001	5	view →
LIHC	All	All	+0.264	.004	5	view →
BRCA	All	II,III,IV	+0.482	<.001	4	view →
COAD	Male	All	+0.457	.002	4	view →
READ	All	III,IV	+0.750	.046	2	view →
STAD	All	II,III,IV	+0.513	.023	2	view →
KIRC	All	All	+0.303	<.001	2	view →
LUAD	Female	II,III,IV	−0.450	.032	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 12 lineages.

CCP110–THCA

Open the THCA breakdown →